R89.8
BillableOth abnormal findings in specimens from oth org/tiss
Other abnormal findings in specimens from other organs, systems and tissues
Coding Notes
Inclusion Terms
Alternative clinical terms for this condition
- Abnormal chromosomal findings in specimens from other organs, systems and tissues
Includes
Conditions included under this code
- abnormal findings in nipple discharge
- abnormal findings in synovial fluid
- abnormal findings in wound secretions
Excludes 1
Codes that cannot be used together with this code (mutual exclusion)
- •abnormal findings on antenatal screening of motherO28
- diagnostic abnormal findings classified elsewhere - see Alphabetical Index
Excludes 2
Conditions not included here, but the patient may have both
- •abnormal findings on antenatal screening of motherO28
- •certain conditions originating in the perinatal periodP04-P96
- signs and symptoms classified in the body system chapters
- •signs and symptoms of breast,N63, N64.5
- •abnormal findings on examination of blood, without diagnosisR70-R79
- •abnormal findings on examination of urine, without diagnosisR80-R82
- •abnormal tumor markersR97
Related Codes(9)
R89.0Abnormal level of enzymes in specimens from oth org/tiss
R89.1Abnormal level of hormones in specimens from oth org/tiss
R89.2Abn lev drug/meds/biol subst in specimens from oth org/tiss
R89.3Abn lev substnc nonmed source in specmn from oth org/tiss
R89.4Abnormal immunolog findings in specimens from oth org/tiss
R89.5Abnormal microbiolog findings in specimens from oth org/tiss
R89.6Abnormal cytological findings in specimens from oth org/tiss
R89.7Abnormal histolog findings in specimens from oth org/tiss
R89.9Unsp abnormal finding in specimens from oth org/tiss
ICD-11 Equivalents(1)
ICD-11 Equivalents
View full mappingCorresponding ICD-11 codes from the WHO crosswalk mapping
Also Known As / Clinical Terms(1384)
SNOMED CT
- Increased molecular dissociation1777007
- Abnormal presence of haemoglobin3720003
- Abnormal presence of hemoglobin3720003
- Increased lactic acid level7501002
- Lactic acid level above reference range7501002
- Abnormal presence of myoglobin9437001
- Laxity12554006
- Laxness12554006
- Gene amplification12645001
- Genetic linkage equilibrium13300001
- Abnormal presence of protein13930000
- Abnormal thickness14028006
- Abnormal macromolecular binding15212002
- Abnormal presence of galactose15268006
- Depolymerisation16315008
- Depolymerization16315008
- Genetic mosaic17523003
- Decrease in circumference18250007
- Abnormally hard consistency19730000
- Hardening19730000
- Decreased size19776001
- Diminution of size19776001
- Inequality in circumference24122006
- Increased urobilinogen level24390000
- Urobilinogen level above reference range24390000
- Abnormal nucleotide base sequence25194005
- Gene re-arrangement, B lymphocyte, heavy chain25900007
- Positive skin test reaction26576000
- Molecular degradation28166001
- Abnormal nucleic acid sequence29286002
- Abnormal molecular cross-linking30453001
- Abnormal presence of glucose31649001
- Macromolecular defective synthesis33002009
- Abnormally soft consistency36350006
- Molecular dissociation36597008
- Retraction37794007
- Increased translucency38638004
- Rarefaction38638004
- Denaturation40241000
- Genetic linkage disequilibrium40976007
- Abnormal amniotic fluid42170009
- Amniotic fluid abnormal42170009
- Gene re-arrangement43245005
- Nucleic acid conformation43996000
- Increase in circumference44832008
- Decreased macromolecular binding44880006
- Strand breaks49030004
- Abnormal presence of pentose51028009
- Increased diameter51381009
- Conformational change52828007
- Macromolecular alteration52828007
- Macromolecular binding53586009
- Genetic mutation55446002
- Increase of specific gravity55759009
- Specific gravity above reference range55759009
- Allelic exclusion60181007
- Genetic inversion60844005
- Gene re-arrangement, gamma chain, T cell antigen receptor61668005
- Decreased uric acid level63192007
- Uric acid level below reference range63192007
- Genetic variation64195000
- Gene re-arrangement, T lymphocyte65247007
- Macromolecular nicking65264005
- Abnormal size65476007
- Molecular instability66115002
- Unstable molecule66115002
- Protein conformation66251001
- Carbohydrate conformation68036007
- Glucose level above reference range68256003
- Increased glucose level68256003
- DNA damage68349007
- DNA injury68349007
- Deoxyribonucleic acid damage68349007
- Cortical blindness68574006
- Abnormal amino acid sequence69604007
- Gene re-arrangement, alpha chain, T cell antigen receptor72644000
- Molecular inactivation72959009
- Shrinkage73238002
- Superhelicity76602008
- Gene re-arrangement, beta chain, T cell antigen receptor78473004
- Abnormal macromolecular sequence79667004
- Macromolecular cleavage81479001
- Abnormal translucency83484004
- Abnormal consistency86991001
- Increased macromolecular binding87523007
- Gene re-arrangement, B lymphocyte87682005
- Decreased translucency87956004
- Decreased molecular dissociation88668007
- Gene re-arrangement, B lymphocyte, light chain89017001
- Abnormal carbohydrate sequence89744004
- Defective molecular assembly89936009
- Molecular conformation90578002
- Acellular smear103607002
- Smear too thick for optimal interpretation103611008
- Specimen too thick for optimal interpretation103611008
- Translucency finding107648000
- Abnormal bone marrow iron110371003
- Absent bone marrow iron110374006
- Extra chromosomal inheritance112212006
- Sample lipaemic118127007
- Sample lipemic118127007
- Specimen lipaemic118127007
- Specimen lipemic118127007
- Sample haemolysed118128002
- Sample hemolyzed118128002
- Specimen haemolysed118128002
- Specimen hemolyzed118128002
- Sample icteric118129005
- Specimen icteric118129005
- Finding by inspection (simple observation)118243007
- Satisfactory for evaluation but limited by partially obscuring thick areas123833004
- Increased ketone bodies123984002
- Ketone bodies above reference range123984002
- Increased orotic acid123986000
- Orotic acid above reference range123986000
- Decreased orotic acid123987009
- Orotic acid below reference range123987009
- Increased xanthine123990003
- Xanthine above reference range123990003
- Decreased xanthine123991004
- Xanthine below reference range123991004
- Homogentisic acid above reference range123993001
- Increased homogentisic acid123993001
- Carbohydrate above reference range123995008
- Increased carbohydrate123995008
- Carbohydrate below reference range123996009
- Decreased carbohydrate123996009
- Fructose above reference range123997000
- Increased fructose123997000
- Decreased fructose123998005
- Fructose below reference range123998005
- Increased lactose124000000
- Lactose above reference range124000000
- Decreased lactose124001001
- Lactose below reference range124001001
- Galactose above reference range124003003
- Increased galactose124003003
- Decreased galactose124004009
- Galactose below reference range124004009
- Increased mannoheptulose124006006
- Mannoheptulose above reference range124006006
- Decreased mannoheptulose124007002
- Mannoheptulose below reference range124007002
- Increased pentose124008007
- Pentose above reference range124008007
- Decreased pentose124009004
- Pentose below reference range124009004
- Glycogen above reference range124011008
- Increased glycogen124011008
- Decreased glycogen124012001
- Glycogen below reference range124012001
- Increased methaemalbumin124016003
- Increased methemalbumin124016003
- Methaemalbumin above reference range124016003
- Methemalbumin above reference range124016003
- Decreased methaemalbumin124017007
- Decreased methemalbumin124017007
- Methaemalbumin below reference range124017007
- Methemalbumin below reference range124017007
- Decreased globulin124020004
- Globulin below reference range124020004
- Decreased protein-bound iodine124030008
- Protein-bound iodine below reference range124030008
- Increased ceroid124038001
- Decreased ceroid124039009
- Abnormal structure of phospholipid124044002
- Abnormal structure of cerebroside124049007
- Amino acid above reference range124056001
- Increased amino acid124056001
- Amino acid below reference range124057005
- Decreased amino acid124057005
- Beta amino isobutyric acid above reference range124059008
- Increased beta amino isobutyric acid124059008
- Beta amino isobutyric acid below reference range124060003
- Decreased beta amino isobutyric acid124060003
- Cystine above reference range124061004
- Increased cystine124061004
- Cystine below reference range124062006
- Decreased cystine124062006
- Histidine above reference range124063001
- Increased histidine124063001
- Decreased histidine124064007
- Histidine below reference range124064007
- Increased tyrosine124065008
- Tyrosine above reference range124065008
- Decreased tyrosine124066009
- Tyrosine below reference range124066009
- Decreased porphyrin124068005
- Porphyrin below reference range124068005
- Decreased uroporphyrin124071002
- Uroporphyrin below reference range124071002
- Bilirubin level below reference range124078008
- Decreased bilirubin level124078008
- Biliverdin above reference range124080002
- Increased biliverdin124080002
- Decreased urobilinogen level124082005
- Urobilinogen level below reference range124082005
- Increased urobilin124085007
- Urobilin above reference range124085007
- Decreased urobilin124086008
- Urobilin below reference range124086008
- Adenylic acid above reference range124088009
- Increased adenosine monophosphate124088009
- Increased adenylic acid124088009
- Adenylic acid below reference range124089001
- Decreased adenosine monophosphate124089001
- Decreased adenylic acid124089001
- Alteration of genetic material124972006
- Somatic mutation124975008
- Temperature-sensitive mutation124976009
- Nucleotide base deletion124977000
- Cell division alteration124978005
- Mitotic alteration124979002
- Increased cell mitotic activity124980004
- Decreased cell mitotic activity124981000
- Mitotic arrest124982007
- Meiotic alteration124988006
- Finding of organ weight125123008
- Abnormal organ weight125125001
- Abnormally increased organ weight125126000
- Abnormally decreased organ weight125127009
- Satisfactory for evaluation but limited by partially obscuring air drying artefact125158005
- Satisfactory for evaluation but limited by partially obscuring air drying artifact125158005
- Choline above reference range127351006
- Increased choline127351006
- Choline below reference range127352004
- Decreased choline127352004
- Finding related to physiologic substance127357005
- Abnormal structure of physiologic substance127359008
- Abnormal quantity of physiologic substance127360003
- Quantity of physiologic substance outside reference range127360003
- Increased vanillylmandelic acid level131040000
- Vanillylmandelic acid level above reference range131040000
- Decreased vanillylmandelic acid level131041001
- Vanillylmandelic acid level below reference range131041001
- Decreased thyroid hormone level131090001
- Thyroid hormone level below reference range131090001
- Increased vitamin A131109009
- Vitamin A above reference range131109009
- Increased vitamin D131113002
- Vitamin D above reference range131113002
- Increased vitamin E131115009
- Vitamin E above reference range131115009
- Increased vitamin K131116005
- Vitamin K above reference range131116005
- Decreased vitamin B131125004
- Vitamin B below reference range131125004
- Increased vitamin B12131126003
- Vitamin B12 above reference range131126003
- Ascorbic acid above reference range131128002
- Increased ascorbic acid131128002
- Increased vitamin C131128002
- Ascorbic acid below reference range131129005
- Decreased ascorbic acid131129005
- Decreased vitamin C131129005
- Folic acid above reference range131132008
- Increased folic acid131132008
- Decreased folic acid131133003
- Folic acid below reference range131133003
- Decreased fibrinogen131177005
- Fibrinogen below reference range131177005
- Monocyte count abnormal165541006
- Monocyte count outside reference range165541006
- AFP - Alpha-fetoprotein raised166561008
- Alpha-fetoprotein above reference range166561008
- Alpha-fetoprotein raised166561008
- Protein electrophoresis abnormal166803003
- Protein electrophoresis outside reference range166803003
- Joint fluid yellow167881006
- Synovial fluid yellow167881006
- Joint fluid cloudy167882004
- Synovial fluid cloudy167882004
- Joint fluid turbid167884003
- Synovial fluid turbid167884003
- Synovial fluid viscosity high167888000
- Synovial fluid viscosity low167889008
- Synovial fluid fibrin clot167891000
- Synovial fluid: fibrin clot +167893002
- Synovial fluid: abnormal content167899003
- Synovial fluid: crystals167902000
- Synovial fluid: uric acid167903005
- Synovial fluid: pyrophosphate167904004
- Bone marrow normoblastic167920009
- Bone marrow megaloblastic167921008
- Bone marrow erythropoiesis hyperplasia167922001
- Calculus = carbaptite168072004
- Calculus = hydroxyapatite168073009
- Calculus = phosphate168075002
- Calculus = cholesterol168077005
- Calculus = bilirubin168078000
- Calculus = triple phosphate168079008
- Amniotic fluid AFP (alpha-fetoprotein) abnormal168109006
- Amniotic fluid alpha-fetoprotein abnormal168109006
- Amniotic fluid alpha-fetoprotein outside reference range168109006
- Cell chromosome examination abnormal168448002
- Amount of liquor249131000
- Finding of amniotic fluid volume249131000
- Finding of quantity of amniotic fluid249131000
- Finding of quantity of liquor249131000
- Observation of quantity of liquor249131000
- Quantity of liquor249131000
- Cold agglutinins detected250256002
- Cold agglutinins present250256002
- Stringing of synovial fluid250534004
- Snowstorm knee250535003
- GU test finding251409007
- GU test observation251409007
- Genitourinary test finding251409007
- Vesicular reaction252100001
- Mucopurulent263815005
- Blood in synovial fluid269909003
- Joint fluid bloody269909003
- Joint fluid haemorrhagic269909003
- Joint fluid hemorrhagic269909003
- Synovial fluid bloodstained269909003
- Phosphate calculus of kidney275893001
- Phosphate kidney stone275893001
- Sample grossly haemolysed281288006
- Sample grossly hemolyzed281288006
- Specimen grossly haemolysed281288006
- Specimen grossly hemolyzed281288006
- Sample slightly haemolysed281289003
- Sample slightly hemolyzed281289003
- Specimen slightly haemolysed281289003
- Specimen slightly hemolyzed281289003
- Sample slightly icteric281290007
- Specimen slightly icteric281290007
- Sample grossly icteric281291006
- Specimen grossly icteric281291006
- Sample grossly lipaemic281292004
- Sample grossly lipemic281292004
- Specimen grossly lipaemic281292004
- Specimen grossly lipemic281292004
- Sample slightly lipaemic281293009
- Sample slightly lipemic281293009
- Specimen slightly lipaemic281293009
- Specimen slightly lipemic281293009
- Aceto-white reaction positive300557001
- Addition-deletion mutation325753009
- Frame-shift mutation325753009
- Reading-frame-shift mutation325753009
- Suppressor mutation326724004
- Nonsense mutation327671006
- Abnormally increased laxity359733004
- Abnormally increased laxness359733004
- Increased laxity359733004
- Increased laxness359733004
- Finding of vitamin B12 level365604004
- Vitamin B12 level365604004
- Finding of monocyte count365631001
- Monocyte count365631001
- Monocyte count - finding365631001
- Finding of presence of crystals365687009
- Presence of crystals365687009
- Presence of crystals - finding365687009
- Finding of presence of ova cysts and parasites365694007
- Presence of ova cysts and parasites365694007
- Presence of ova cysts and parasites - finding365694007
- Finding of synovial fluid viscosity365710005
- Synovial fluid viscosity - finding365710005
- Finding of synovial fluid composition365711009
- Synovial fluid composition - finding365711009
- Finding of synovial fluid appearance365712002
- Bilirubin level365786009
- Bilirubin level - finding365786009
- Finding of bilirubin level365786009
- Calculus chemical composition365789002
- Calculus chemical composition - finding365789002
- Finding of calculus chemical composition365789002
- Amniotic fluid AFP365827005
- Amniotic fluid AFP - finding365827005
- Finding of amniotic fluid alpha-fetoprotein365827005
- Finding of specific gravity365828000
- Specific gravity365828000
- Specific gravity - finding365828000
- Finding of bone marrow erythropoiesis365835008
- Aceto-white reaction finding366318009
- Contact sensitivity response - finding366665009
- Finding of contact sensitivity response366665009
- Fragmented tissue specimen395528004
- Tissue specimen fragmented395528004
- Tissue specimen ruptured397332005
- Fetal tissue present in specimen397475000
- Foetal tissue present in specimen397475000
- Fetal anomaly present in specimen405999008
- Foetal anomaly present in specimen405999008
- Genetic finding detected412731001
- Positive genetic finding412731001
- Bone marrow iron finding413680005
- Granulocyte count below reference range416955003
- Granulopenia416955003
- Mitochondrial mutation430934002
- Cholesterol/high density lipoprotein ratio above reference range439953004
- Elevated cholesterol/high density lipoprotein ratio439953004
- Influenza A virus subtype H1 detected441043003
- Influenza A virus subtype H1 present441043003
- Karyotype evaluation abnormal442124003
- Measurement finding below reference range442686002
- Measurement finding above reference range442756004
- Cancer antigen 27-29 above reference range444764006
- High cancer antigen 27-29 level444764006
- Specimen involvement by multifocal invasion444902000
- Breast cancer genetic marker of susceptibility detected445333001
- Breast cancer genetic marker of susceptibility positive445333001
- Effect of antiestrogen agent445963000
- Effect of antioestrogen agent445963000
- Finding of oxygen saturation447755005
- Point mutation471281007
- Influenza A H1N1 virus 2009 pandemic strain present702482001
- Mitochondrial 1555 A to G mutation detected702782002
- Mitochondrial 1555 A to G mutation positive702782002
- Heterozygous protocadherin 19 gene mutation detected702783007
- Heterozygous protocadherin 19 gene mutation positive702783007
- Suture material present718569006
- Mutation of p53 gene719007008
- Mutation of p53 gene present719007008
- Positive for tumor protein p53719007008
- Positive for tumour protein p53719007008
- Tumor protein p53 detected719007008
- Tumour protein p53 detected719007008
- Needle shaped crystals present720353000
- CYP2C9 poor metaboliser738545001
- CYP2C9 poor metabolizer738545001
- Cytochrome P450 family 2 subfamily C member 9 poor metaboliser738545001
- Cytochrome P450 family 2 subfamily C member 9 poor metabolizer738545001
- CYP2C19 rapid metaboliser738789003
- CYP2C19 rapid metabolizer738789003
- Cytochrome P450 family 2 subfamily C member 19 rapid metaboliser738789003
- Cytochrome P450 family 2 subfamily C member 19 rapid metabolizer738789003
- CMMR-D (constitutional mismatch repair deficiency) syndrome764946008
- Constitutional mismatch repair deficiency syndrome764946008
- VKORC1 (vitamin K epoxide reductase complex 1) poor metaboliser787128002
- VKORC1 (vitamin K epoxide reductase complex 1) poor metabolizer787128002
- VKORC1 poor metaboliser787128002
- VKORC1 poor metabolizer787128002
- Vitamin K epoxide reductase complex 1 poor metaboliser787128002
- Vitamin K epoxide reductase complex 1 poor metabolizer787128002
- VKORC1 (vitamin K epoxide reductase complex 1) rapid metaboliser787133003
- VKORC1 (vitamin K epoxide reductase complex 1) rapid metabolizer787133003
- VKORC1 rapid metaboliser787133003
- VKORC1 rapid metabolizer787133003
- Vitamin K epoxide reductase complex 1 rapid metaboliser787133003
- Vitamin K epoxide reductase complex 1 rapid metabolizer787133003
- VKORC1 (vitamin K epoxide reductase complex 1) ultra-rapid metaboliser787134009
- VKORC1 (vitamin K epoxide reductase complex 1) ultra-rapid metabolizer787134009
- VKORC1 ultra-rapid metaboliser787134009
- VKORC1 ultra-rapid metabolizer787134009
- Vitamin K epoxide reductase complex 1 ultra-rapid metaboliser787134009
- Vitamin K epoxide reductase complex 1 ultra-rapid metabolizer787134009
- CYP2C9 (cytochrome P450 family 2 subfamily C member 9) ultra-rapid metaboliser787192006
- CYP2C9 (cytochrome P450 family 2 subfamily C member 9) ultra-rapid metabolizer787192006
- CYP2C9 ultra-rapid metaboliser787192006
- CYP2C9 ultra-rapid metabolizer787192006
- Cytochrome P450 family 2 subfamily C member 9 ultra-rapid metaboliser787192006
- Cytochrome P450 family 2 subfamily C member 9 ultra-rapid metabolizer787192006
- CYP2C9 (cytochrome P450 family 2 subfamily C member 9) rapid metaboliser787193001
- CYP2C9 (cytochrome P450 family 2 subfamily C member 9) rapid metabolizer787193001
- CYP2C9 rapid metaboliser787193001
- CYP2C9 rapid metabolizer787193001
- Cytochrome P450 family 2 subfamily C member 9 rapid metaboliser787193001
- Cytochrome P450 family 2 subfamily C member 9 rapid metabolizer787193001
- CYP1A2 (cytochrome P450 family 1 subfamily A member 2) poor metaboliser787363003
- CYP1A2 (cytochrome P450 family 1 subfamily A member 2) poor metabolizer787363003
- CYP1A2 poor metaboliser787363003
- CYP1A2 poor metabolizer787363003
- Cytochrome P450 family 1 subfamily A member 2 poor metaboliser787363003
- Cytochrome P450 family 1 subfamily A member 2 poor metabolizer787363003
- CYP1A2 (cytochrome P450 family 1 subfamily A member 2) rapid metaboliser787367002
- CYP1A2 (cytochrome P450 family 1 subfamily A member 2) rapid metabolizer787367002
- CYP1A2 rapid metaboliser787367002
- CYP1A2 rapid metabolizer787367002
- Cytochrome P450 family 1 subfamily A member 2 rapid metaboliser787367002
- Cytochrome P450 family 1 subfamily A member 2 rapid metabolizer787367002
- CYP1A2 (cytochrome P450 family 1 subfamily A member 2) ultra-rapid metaboliser787369004
- CYP1A2 (cytochrome P450 family 1 subfamily A member 2) ultra-rapid metabolizer787369004
- CYP1A2 ultra-rapid metaboliser787369004
- CYP1A2 ultra-rapid metabolizer787369004
- Cytochrome P450 family 1 subfamily A member 2 ultra-rapid metaboliser787369004
- Cytochrome P450 family 1 subfamily A member 2 ultra-rapid metabolizer787369004
- CYP3A4 (cytochrome P450 family 3 subfamily A member 4) poor metaboliser787380004
- CYP3A4 (cytochrome P450 family 3 subfamily A member 4) poor metabolizer787380004
- CYP3A4 poor metaboliser787380004
- CYP3A4 poor metabolizer787380004
- Cytochrome P450 family 3 subfamily A member 4 poor metaboliser787380004
- Cytochrome P450 family 3 subfamily A member 4 poor metabolizer787380004
- CYP3A4 (cytochrome P450 family 3 subfamily A member 4) rapid metaboliser787385009
- CYP3A4 (cytochrome P450 family 3 subfamily A member 4) rapid metabolizer787385009
- CYP3A4 rapid metaboliser787385009
- CYP3A4 rapid metabolizer787385009
- Cytochrome P450 family 3 subfamily A member 4 rapid metaboliser787385009
- Cytochrome P450 family 3 subfamily A member 4 rapid metabolizer787385009
- CYP3A4 (cytochrome P450 family 3 subfamily A member 4) ultra-rapid metaboliser787386005
- CYP3A4 (cytochrome P450 family 3 subfamily A member 4) ultra-rapid metabolizer787386005
- CYP3A4 ultra-rapid metaboliser787386005
- CYP3A4 ultra-rapid metabolizer787386005
- Cytochrome P450 family 3 subfamily A member 4 ultra-rapid metaboliser787386005
- Cytochrome P450 family 3 subfamily A member 4 ultra-rapid metabolizer787386005
- CYP3A5 (cytochrome P450 family 3 subfamily A member 5) ultra-rapid metaboliser787406007
- CYP3A5 (cytochrome P450 family 3 subfamily A member 5) ultra-rapid metabolizer787406007
- CYP3A5 ultra-rapid metaboliser787406007
- CYP3A5 ultra-rapid metabolizer787406007
- Cytochrome P450 family 3 subfamily A member 5 ultra-rapid metaboliser787406007
- Cytochrome P450 family 3 subfamily A member 5 ultra-rapid metabolizer787406007
- CYP2D6 (cytochrome P450 family 2 subfamily D member 6) rapid metaboliser787433006
- CYP2D6 (cytochrome P450 family 2 subfamily D member 6) rapid metabolizer787433006
- CYP2D6 rapid metaboliser787433006
- CYP2D6 rapid metabolizer787433006
- Cytochrome P450 family 2 subfamily D member 6 rapid metaboliser787433006
- Cytochrome P450 family 2 subfamily D member 6 rapid metabolizer787433006
- HPV (human papillomavirus) DNA (deoxyribonucleic acid) test positive787723002
- Human papillomavirus deoxyribonucleic acid detected787723002
- Human papillomavirus deoxyribonucleic acid test positive787723002
- Arylamine N-acetyltransferase 2 slow acetylator792857006
- N-acetyltransferase 2 slow acetylator792857006
- NAT 2 (N-acetyltransferase 2) poor metaboliser792857006
- NAT 2 (N-acetyltransferase 2) poor metabolizer792857006
- NAT2 (N-acetyltransferase 2) slow acetylator792857006
- Genetic susceptibility to malignant hyperthermia890189007
- Malignant hyperthermia genetic susceptibility890189007
- CYP4F2 (cytochrome P450 family 4 subfamily F member 2) poor metaboliser1003612008
- CYP4F2 (cytochrome P450 family 4 subfamily F member 2) poor metabolizer1003612008
- CYP4F2 poor metaboliser1003612008
- CYP4F2 poor metabolizer1003612008
- Cytochrome P450 family 4 subfamily F member 2 poor metaboliser1003612008
- Cytochrome P450 family 4 subfamily F member 2 poor metabolizer1003612008
- Genetic susceptibility to malignant hyperthermia due to calcium voltage-gated channel subunit alpha1 S gene mutation1141749000
- Genetic susceptibility to malignant hyperthermia due to calcium voltage-gated channel subunit alpha1 S gene mutation positive1141749000
- Malignant hyperthermia predisposition due to CACNA1S (calcium voltage-gated channel subunit alpha1 S) gene mutation positive1141749000
- Uncertain genetic susceptibility to malignant hyperthermia due to ryanodine receptor 1 gene mutation1142134000
- Uncertain malignant hyperthermia predisposition due to RyR1 gene mutation1142134000
- CYP2C9 *3/*3 poor metaboliser1144910008
- CYP2C9 *3/*3 poor metabolizer1144910008
- Cytochrome P450 family 2 subfamily C member 9 *3/*3 poor metaboliser1144910008
- Cytochrome P450 family 2 subfamily C member 9 *3/*3 poor metabolizer1144910008
- CYP2C9 *2/*3 poor metaboliser1144930007
- CYP2C9 *2/*3 poor metabolizer1144930007
- Cytochrome P450 family 2 subfamily C member 9 *2/*3 poor metaboliser1144930007
- Cytochrome P450 family 2 subfamily C member 9 *2/*3 poor metabolizer1144930007
- HER2 (human epidermal growth factor receptor 2) gene amplification detected1162602001
- Human epidermal growth factor receptor 2 gene amplification detected1162602001
- Amniotic fluid alpha-fetoprotein above reference range1172710005
- Progressive microcephaly, seizures, cortical blindness, developmental delay syndrome1172900005
- Amniotic fluid volume below reference range1228877003
- Finding of oligohydramnios1228877003
- Liquor volume below reference range1228877003
- CK-19 (cytokeratin-19) fragment above reference range1254667009
- CYFRA 21-1 above reference range1254667009
- Cytokeratin 19 fragment above reference range1254667009
- K19 (keratin-19) fragment above reference range1254667009
- Keratin, type I cytoskeletal 19 fragment above reference range1254667009
- High risk HPV (human papillomavirus) DNA (deoxyribonucleic acid) detected1269497006
- High risk human papillomavirus deoxyribonucleic acid detected1269497006
- High risk human papillomavirus deoxyribonucleic acid test positive1269497006
- High-risk HPV (human papillomavirus) DNA test positive1269497006
- Heterozygous NFKB inhibitor alpha gene mutation detected1279971008
- Heterozygous NFKBIA gene mutation detected1279971008
- Heterozygous NFKBIA gene mutation positive1279971008
- Heterozygous nuclear factor of kappa light polypeptide gene enhancer In B-cells inhibitor, alpha gene mutation positive1279971008
- Missense1306850007
- Missense mutation1306850007
- Splice site mutation1306851006
- Intron 1 inversion1306859008
- Inv1 - intron 1 inversion1306859008
- Intron 22 inversion1306860003
- Inv22 - intron 22 inversion1306860003
- Synonymous single nucleotide substitution1306861004
- Structural variant1331913009
- Small deletion1336122005
- Small insertion1336123000
- Mutation of promoter1336206001
- Promoter mutation1336206001
- Mutation of untranslated region1336209008
- UTR (untranslated region) mutation1336209008
- ABCG2 poor function1351232003
- ATP binding cassette subfamily G member 2 poor function1351232003
- ABCG2 decreased function1351233008
- ATP binding cassette subfamily G member 2 decreased function1351233008
- Autosomal dominant combined immunodeficiency due to STAT5b deficiency1351779004
- Autosomal dominant combined immunodeficiency due to STAT5b mutation1351779004
- Autosomal dominant combined immunodeficiency due to signal transducer and activator of transcription 5B mutation1351779004
- Autosomal recessive combined immunodeficiency due to REL mutation1351780001
- Autosomal recessive combined immunodeficiency due to REL proto-oncogene NF-kappa-B subunit mutation1351780001
- Autosomal recessive combined immunodeficiency due to c-Rel deficiency1351780001
- Autosomal recessive combined immunodeficiency due to BCL10 deficiency1351781002
- Autosomal recessive combined immunodeficiency due to BCL10 immune signaling adaptor mutation1351781002
- Autosomal recessive combined immunodeficiency due to BCL10 mutation1351781002
- Autosomal recessive combined immunodeficiency due to CHUK mutation1351800009
- Autosomal recessive combined immunodeficiency due to IKK-alpha deficiency1351800009
- Autosomal recessive combined immunodeficiency due to component of inhibitor of nuclear factor kappa B kinase complex mutation1351800009
- Combined immunodeficiency due to HELIOS deficiency1351801008
- Combined immunodeficiency due to IKAROS family zinc finger 2 mutation1351801008
- Combined immunodeficiency due to IKZF2 mutation1351801008
- Autosomal recessive combined immunodeficiency due to ITPKB deficiency1351802001
- Autosomal recessive combined immunodeficiency due to ITPKB mutation1351802001
- Autosomal recessive combined immunodeficiency due to inositol-trisphosphate 3-kinase B mutation1351802001
- Autosomal recessive combined immunodeficiency due to MAN2B2 deficiency1351946008
- Autosomal recessive combined immunodeficiency due to MAN2B2 mutation1351946008
- Autosomal recessive combined immunodeficiency due to mannosidase alpha class 2B member 2 mutation1351946008
- Oxygen saturation above reference range1351951002
- Autosomal recessive CVID (common variable immunodeficiency) due to CD20 deficiency1351960005
- Autosomal recessive common variable immunodeficiency due to CD20 deficiency1351960005
- Autosomal recessive common variable immunodeficiency due to CD20 mutation1351960005
- Autosomal recessive common variable immunodeficiency due to MS4A1 mutation1351960005
- Autosomal recessive common variable immunodeficiency due to membrane spanning 4-domains A1 mutation1351960005
- Autosomal recessive CVID (common variable immunodeficiency) due to CD21 deficiency1351961009
- Autosomal recessive common variable immunodeficiency due to CD21 deficiency1351961009
- Autosomal recessive common variable immunodeficiency due to CD21 mutation1351961009
- Autosomal recessive common variable immunodeficiency due to CR2 mutation1351961009
- Autosomal recessive common variable immunodeficiency due to complement C3d receptor 2 mutation1351961009
- Autosomal recessive CVID (combined variable immunodeficiency) due to TNFRSF13C mutation1352023006
- Autosomal recessive combined variable immunodeficiency due to B cell-activating factor receptor mutation1352023006
- Autosomal recessive combined variable immunodeficiency due to BAFF receptor deficiency1352023006
- Autosomal recessive combined variable immunodeficiency due to BAFF-R deficiency1352023006
- Autosomal recessive combined variable immunodeficiency due to BAFF-R mutation1352023006
- Autosomal dominant CVID (combined variable immunodeficiency) due to TNFSF12 mutation1352026003
- Autosomal dominant combined variable immunodeficiency due to TWEAK deficiency1352026003
- Autosomal dominant combined variable immunodeficiency due to TWEAK mutation1352026003
- Autosomal dominant combined variable immunodeficiency due to tumor necrosis factor-like weak inducer of apoptosis mutation1352026003
- Autosomal dominant combined variable immunodeficiency due to tumour necrosis factor-like weak inducer of apoptosis mutation1352026003
- Autosomal dominant CVID (combined variable immunodeficiency) due to NFKB1 deficiency1354416002
- Autosomal dominant combined variable immunodeficiency due to NFKB1 deficiency1354416002
- Autosomal dominant combined variable immunodeficiency due to NFKB1 mutation1354416002
- Autosomal dominant combined variable immunodeficiency due to nuclear factor kappa B subunit 1 mutation1354416002
- Autosomal dominant CVID (combined variable immunodeficiency) due to IRF2BP2 deficiency1354420003
- Autosomal dominant combined variable immunodeficiency due to IRF2BP2 deficiency1354420003
- Autosomal dominant combined variable immunodeficiency due to IRF2BP2 mutation1354420003
- Autosomal dominant combined variable immunodeficiency due to interferon regulatory factor 2 binding protein 2 mutation1354420003
- Autosomal recessive CVID (combined variable immunodeficiency) due to ARHGEF1 deficiency1354472008
- Autosomal recessive combined variable immunodeficiency due to ARHGEF1 deficiency1354472008
- Autosomal recessive combined variable immunodeficiency due to ARHGEF1 mutation1354472008
- Autosomal recessive combined variable immunodeficiency due to Rho guanine nucleotide exchange factor 1 mutation1354472008
- Autosomal dominant CVID (combined variable immunodeficiency) due to SEC61A1 deficiency1354480001
- Autosomal dominant combined variable immunodeficiency due to SEC61 translocon subunit alpha 1 mutation1354480001
- Autosomal dominant combined variable immunodeficiency due to SEC61A1 deficiency1354480001
- Autosomal dominant combined variable immunodeficiency due to SEC61A1 mutation1354480001
- Autosomal recessive CVID (combined variable immunodeficiency) due to PIK3CG deficiency1354483004
- Autosomal recessive combined variable immunodeficiency due to PIK3CG deficiency1354483004
- Autosomal recessive combined variable immunodeficiency due to PIK3CG mutation1354483004
- Autosomal recessive combined variable immunodeficiency due to phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma mutation1354483004
- Autosomal recessive common variable immunodeficiency due to BOB1 deficiency1354596000
- Autosomal recessive common variable immunodeficiency due to POU class 2 homeobox associating factor 1 mutation1354596000
- Autosomal recessive common variable immunodeficiency due to POU2AF1 mutation1354596000
- Progressive microcephaly, seizures, cortical blindness, developmental delay syndrome with combined immunodeficiency due to diaphanous related formin 1 mutation1354858008
- Progressive microcephaly, seizures, cortical blindness, developmental delay with combined immunodeficiency due to DIAPH1 deficiency1354858008
- Progressive microcephaly, seizures, cortical blindness, developmental delay with combined immunodeficiency due to DIAPH1 mutation1354858008
- SCBMS (seizures, cortical blindness, microcephaly syndrome) with combined immunodeficiency due to DIAPH1 mutation1354858008
- Constitutional mismatch repair deficiency syndrome due to PMS1 homolog 2, mismatch repair system component mutation1356823008
- Constitutional mismatch repair deficiency syndrome due to PMS2 deficiency1356823008
- Constitutional mismatch repair deficiency syndrome due to PMS2 mutation1356823008
- PTEN (phosphatase and tensin homolog) gene mutation detected1357792009
- Phosphatase and tensin homolog gene mutation detected1357792009
- CYP2C9 *5/*6 poor metaboliser1363066005
- CYP2C9 *5/*6 poor metabolizer1363066005
- Cytochrome P450 family 2 subfamily C member 9 *5/*6 poor metaboliser1363066005
- Cytochrome P450 family 2 subfamily C member 9 *5/*6 poor metabolizer1363066005
- CYP2C9 *6/*6 poor metaboliser1363067001
- CYP2C9 *6/*6 poor metabolizer1363067001
- Cytochrome P450 family 2 subfamily C member 9 *6/*6 poor metaboliser1363067001
- Cytochrome P450 family 2 subfamily C member 9 *6/*6 poor metabolizer1363067001
- CYP2C9 *6/*8 poor metaboliser1363069003
- CYP2C9 *6/*8 poor metabolizer1363069003
- Cytochrome P450 family 2 subfamily C member 9 *6/*8 poor metaboliser1363069003
- Cytochrome P450 family 2 subfamily C member 9 *6/*8 poor metabolizer1363069003
- CYP2C9 *6/*11 poor metaboliser1363070002
- CYP2C9 *6/*11 poor metabolizer1363070002
- Cytochrome P450 family 2 subfamily C member 9 *6/*11 poor metaboliser1363070002
- Cytochrome P450 family 2 subfamily C member 9 *6/*11 poor metabolizer1363070002
- Lynch syndrome gene mutation detected1365861003
- High risk variant of APOL1 (apolipoprotein L1) gene detected1365952004
- High risk variant of apolipoprotein L1 gene detected1365952004
- Low risk variant of APOL1 (apolipoprotein L1) gene detected1365954003
- Low risk variant of apolipoprotein L1 gene detected1365954003
- B-Raf serine/threonine kinase gene mutation detected961321000124101
- BRAF serine threonine kinase gene mutation detected961321000124101
- BRAF serine threonine kinase gene mutation positive961321000124101
- Down syndrome detected by multiple marker screening130081000119101
- Multiple marker screen positive for Down syndrome130081000119101
- Multiple marker screening test positive for Down syndrome130081000119101
- Triple screening test positive for Down syndrome130081000119101
- Genetic susceptibility to cancer85121000119109
- Genetic susceptibility to genetic disorder71951000119107
- High risk HPV (human papillomavirus) test positive97401000146106
- High risk human papillomavirus detected97401000146106
- High risk human papillomavirus positive97401000146106
- Increased nuchal translucency detected by multiple marker screening286571000119101
- Multiple marker screen positive for increased nuchal translucency286571000119101
- Multiple marker screen positive for trisomy 18130071000119104
- Trisomy 18 detected by multiple marker screening130071000119104
- Triplicated alpha globin gene689861000119100
- Triplication of alpha globin gene689861000119100
UMLS
Clinical Terms
- Bone marrow erythropoiesis hyperplasia
- Galactose below reference range
- Molecular dissociation
- Increase of specific gravity
- Influenza A virus subtype H1 detected
- Constitutional mismatch repair deficiency syndrome due to PMS1 homolog 2, mismatch repair system component mutation
- CYP2C9 *3/*3 poor metabolizer
- Hardening
- Calculus chemical composition - finding
- Acellular smear
- Abnormally hard consistency
- Autosomal dominant combined variable immunodeficiency due to NFKB1 deficiency
- CYP2C9 ultra-rapid metaboliser
- Increased glucose level
- Cytochrome P450 family 1 subfamily A member 2 poor metabolizer
- Calculus = bilirubin
- Deoxyribonucleic acid damage
- Macromolecular defective synthesis
- DNA damage
- Synovial fluid viscosity - finding
- Laxness
- Intron 22 inversion
- Finding by inspection (simple observation)
- Uroporphyrin below reference range
- Cytochrome P450 family 2 subfamily C member 9 *3/*3 poor metaboliser
- Genetic mutation
- ABCG2 poor function
- Presence of crystals
- Constitutional mismatch repair deficiency syndrome due to PMS2 mutation
- Protein conformation
- Abnormal presence of glucose
- Abnormally increased laxity
- VKORC1 (vitamin K epoxide reductase complex 1) poor metaboliser
- Malignant hyperthermia predisposition due to CACNA1S (calcium voltage-gated channel subunit alpha1 S) gene mutation positive
- CYP3A4 (cytochrome P450 family 3 subfamily A member 4) poor metabolizer
- Autosomal recessive common variable immunodeficiency due to membrane spanning 4-domains A1 mutation
- Abnormal organ weight
- Increased macromolecular binding
- Arylamine N-acetyltransferase 2 slow acetylator
- Vitamin K epoxide reductase complex 1 ultra-rapid metabolizer
- Decreased orotic acid
- Genetic linkage disequilibrium
- Abnormal size
- Tyrosine below reference range
- HER2 (human epidermal growth factor receptor 2) gene amplification detected
- Autosomal dominant combined immunodeficiency due to STAT5b deficiency
- Autosomal recessive combined immunodeficiency due to MAN2B2 mutation
- Needle shaped crystals present
- CYP4F2 (cytochrome P450 family 4 subfamily F member 2) poor metaboliser
- Specimen grossly icteric
- Protein electrophoresis abnormal
- Specific gravity above reference range
- Joint fluid turbid
- Synovial fluid: crystals
- Autosomal dominant combined variable immunodeficiency due to SEC61A1 mutation
- Finding of vitamin B12 level
- GU test observation
- Nucleic acid conformation
- Genetic susceptibility to cancer
- Carbohydrate conformation
- Increased translucency
- CYP2C9 *2/*3 poor metaboliser
- B-Raf serine/threonine kinase gene mutation detected
- Cancer antigen 27-29 above reference range
- Genetic mosaic
- Inv1 - intron 1 inversion
- Mannoheptulose above reference range
- Urobilin below reference range
- Autosomal recessive common variable immunodeficiency due to complement C3d receptor 2 mutation
- Autosomal recessive combined variable immunodeficiency due to ARHGEF1 deficiency
- VKORC1 ultra-rapid metabolizer
- Finding of specific gravity
- Decreased galactose
- Abnormal chromosomal findings in specimens from other organs, systems and tissues
- Human papillomavirus deoxyribonucleic acid detected
- Abnormal nucleic acid sequence
- Cytochrome P450 family 2 subfamily C member 9 *6/*8 poor metaboliser
- CYP2C9 (cytochrome P450 family 2 subfamily C member 9) ultra-rapid metabolizer
- Increased glycogen
- CYP3A5 (cytochrome P450 family 3 subfamily A member 5) ultra-rapid metaboliser
- CYP1A2 poor metabolizer
- Increased methemalbumin
- Specimen slightly icteric
- ABCG2 decreased function
- Autosomal recessive combined variable immunodeficiency due to BAFF-R mutation
- Joint fluid yellow
- Presence of ova cysts and parasites
- Tumor protein p53 detected
- Molecular inactivation
- Synovial fluid: abnormal content
- Specimen hemolyzed
- Amino acid below reference range
- Monocyte count - finding
- CYP2C9 ultra-rapid metabolizer
- Decreased methemalbumin
- Cytochrome P450 family 3 subfamily A member 5 ultra-rapid metaboliser
- Decreased porphyrin
- Abnormal presence of hemoglobin
- Methaemalbumin below reference range
- Amniotic fluid alpha-fetoprotein abnormal
- Carbohydrate above reference range
- Pentose above reference range
- CYP2C9 *6/*11 poor metabolizer
- CYP3A4 (cytochrome P450 family 3 subfamily A member 4) poor metaboliser
- Autosomal dominant combined variable immunodeficiency due to TWEAK mutation
- Cytochrome P450 family 1 subfamily A member 2 rapid metabolizer
- Histidine below reference range
- BRAF serine threonine kinase gene mutation positive
- Amniotic fluid AFP - finding
- Cytochrome P450 family 4 subfamily F member 2 poor metaboliser
- Ascorbic acid below reference range
- Increased xanthine
- Vitamin B below reference range
- SCBMS (seizures, cortical blindness, microcephaly syndrome) with combined immunodeficiency due to DIAPH1 mutation
- Cell division alteration
- Vitamin D above reference range
- Increased fructose
- CYP3A5 ultra-rapid metaboliser
- Increased laxity
- Adenylic acid below reference range
- Genetic finding detected
- CYP1A2 (cytochrome P450 family 1 subfamily A member 2) poor metaboliser
- Combined immunodeficiency due to IKAROS family zinc finger 2 mutation
- Bone marrow megaloblastic
- Mitotic arrest
- Biliverdin above reference range
- Heterozygous NFKBIA gene mutation detected
- Combined immunodeficiency due to HELIOS deficiency
- Calculus = hydroxyapatite
- Decreased amino acid
- Increased lactic acid level
- CYP2C9 *3/*3 poor metaboliser
- Increased galactose
- Breast cancer genetic marker of susceptibility detected
- Abnormal presence of protein
- CYP3A4 rapid metaboliser
- Abnormal nucleotide base sequence
- Decreased ceroid
- Finding of quantity of amniotic fluid
- Mucopurulent
- Specimen grossly lipaemic
- Trisomy 18 detected by multiple marker screening
- Abnormal macromolecular binding
- Suture material present
- Observation of quantity of liquor
- Increased ketone bodies
- CYP2C9 poor metabolizer
- Heterozygous protocadherin 19 gene mutation detected
- VKORC1 (vitamin K epoxide reductase complex 1) rapid metabolizer
- NAT 2 (N-acetyltransferase 2) poor metabolizer
- Alteration of genetic material
- Autosomal recessive CVID (combined variable immunodeficiency) due to TNFRSF13C mutation
- Autosomal recessive combined variable immunodeficiency due to PIK3CG mutation
- Abnormally increased organ weight
- Missense
- Snowstorm knee
- Small insertion
- Malignant hyperthermia genetic susceptibility
- CYP2C9 *5/*6 poor metaboliser
- Protein-bound iodine below reference range
- DNA injury
- Amniotic fluid abnormal
- Mitochondrial 1555 A to G mutation detected
- Cytochrome P450 family 2 subfamily C member 9 *3/*3 poor metabolizer
- Decreased molecular dissociation
- Cortical blindness
- Decreased lactose
- Suppressor mutation
- Constitutional mismatch repair deficiency syndrome due to PMS2 deficiency
- Small deletion
- Gene re-arrangement, B lymphocyte
- Sample hemolyzed
- Fibrinogen below reference range
- Urobilin above reference range
- Quantity of liquor
- Sample slightly lipaemic
- Abnormal carbohydrate sequence
- Synovial fluid turbid
- Inequality in circumference
- Genetic susceptibility to genetic disorder
- Pentose below reference range
- Gene re-arrangement, T lymphocyte
- Autosomal dominant combined variable immunodeficiency due to nuclear factor kappa B subunit 1 mutation
- Decreased vitamin C
- Porphyrin below reference range
- Decreased size
- Finding of amniotic fluid alpha-fetoprotein
- Specimen lipemic
- Glycogen above reference range
- CYP4F2 poor metaboliser
- Increased urobilin
- Increased vitamin K
- Vitamin B12 above reference range
- Synovial fluid viscosity low
- Decreased glycogen
- Abnormal bone marrow iron
- Multiple marker screen positive for increased nuchal translucency
- CYP1A2 (cytochrome P450 family 1 subfamily A member 2) poor metabolizer
- Specific gravity
- Uric acid level below reference range
- Cytochrome P450 family 3 subfamily A member 4 ultra-rapid metabolizer
- Granulopenia
- Increased ascorbic acid
- Homogentisic acid above reference range
- Autosomal recessive common variable immunodeficiency due to POU2AF1 mutation
- Abnormal presence of galactose
- Translucency finding
- CYP2C9 rapid metaboliser
- Cytochrome P450 family 2 subfamily C member 9 *6/*8 poor metabolizer
- Amniotic fluid AFP
- High risk human papillomavirus deoxyribonucleic acid test positive
- Calculus = phosphate
- Cytochrome P450 family 3 subfamily A member 4 rapid metabolizer
- Xanthine below reference range
- Abnormal amniotic fluid
- Decrease in circumference
- Decreased translucency
- Lynch syndrome gene mutation detected
- Amniotic fluid alpha-fetoprotein above reference range
- Finding of contact sensitivity response
- Frame-shift mutation
- Finding of synovial fluid viscosity
- Cytochrome P450 family 1 subfamily A member 2 poor metaboliser
- CYP1A2 poor metaboliser
- Increased amino acid
- Mitotic alteration
- Specimen haemolysed
- CYP1A2 (cytochrome P450 family 1 subfamily A member 2) ultra-rapid metabolizer
- Sample slightly icteric
- Decreased bilirubin level
- CYP1A2 ultra-rapid metaboliser
- CYP2C9 *6/*11 poor metaboliser
- Abnormal structure of physiologic substance
- Increased molecular dissociation
- Histidine above reference range
- Uncertain malignant hyperthermia predisposition due to RyR1 gene mutation
- Autosomal recessive CVID (common variable immunodeficiency) due to CD21 deficiency
- Globulin below reference range
- High risk variant of apolipoprotein L1 gene detected
- Vitamin K epoxide reductase complex 1 ultra-rapid metaboliser
- CK-19 (cytokeratin-19) fragment above reference range
- Macromolecular cleavage
- Cell chromosome examination abnormal
- Multiple marker screen positive for Down syndrome
- Cystine above reference range
- Calculus = carbaptite
- Cytochrome P450 family 2 subfamily C member 9 poor metaboliser
- Cytochrome P450 family 2 subfamily C member 9 *5/*6 poor metaboliser
- Molecular degradation
- Gene re-arrangement
- Specimen grossly lipemic
- Cytochrome P450 family 3 subfamily A member 4 poor metabolizer
- Gene amplification
- Synovial fluid cloudy
- Vanillylmandelic acid level below reference range
- Beta amino isobutyric acid above reference range
- Decreased vanillylmandelic acid level
- Amino acid above reference range
- Cold agglutinins present
- Methaemalbumin above reference range
- Decreased tyrosine
- Choline above reference range
- Calculus chemical composition
- Autosomal dominant CVID (combined variable immunodeficiency) due to IRF2BP2 deficiency
- Heterozygous NFKB inhibitor alpha gene mutation detected
- CYP3A4 ultra-rapid metabolizer
- Synovial fluid: uric acid
- Amniotic fluid alpha-fetoprotein outside reference range
- Increased adenylic acid
- Decreased carbohydrate
- Finding of synovial fluid composition
- Cytochrome P450 family 4 subfamily F member 2 poor metabolizer
- Synovial fluid viscosity high
- Autosomal recessive combined variable immunodeficiency due to Rho guanine nucleotide exchange factor 1 mutation
- Autosomal dominant combined variable immunodeficiency due to SEC61A1 deficiency
- CYP2C9 rapid metabolizer
- CYFRA 21-1 above reference range
- Finding of oxygen saturation
- Cytochrome P450 family 1 subfamily A member 2 ultra-rapid metaboliser
- Uncertain genetic susceptibility to malignant hyperthermia due to ryanodine receptor 1 gene mutation
- Contact sensitivity response - finding
- Methemalbumin above reference range
- Increased cystine
- Promoter mutation
- Triplication of alpha globin gene
- Monocyte count outside reference range
- Low risk variant of APOL1 (apolipoprotein L1) gene detected
- Vitamin B12 level
- Autosomal recessive combined immunodeficiency due to mannosidase alpha class 2B member 2 mutation
- Cytochrome P450 family 2 subfamily C member 9 rapid metaboliser
- CYP2C9 *6/*8 poor metabolizer
- Progressive microcephaly, seizures, cortical blindness, developmental delay with combined immunodeficiency due to DIAPH1 deficiency
- Satisfactory for evaluation but limited by partially obscuring air drying artifact
- Increased pentose
- High risk human papillomavirus detected
- Specimen slightly hemolyzed
- Autosomal recessive common variable immunodeficiency due to CD20 deficiency
- Autosomal dominant combined immunodeficiency due to signal transducer and activator of transcription 5B mutation
- Decreased urobilin
- Glycogen below reference range
- Abnormal quantity of physiologic substance
- CYP2D6 (cytochrome P450 family 2 subfamily D member 6) rapid metaboliser
- Increased cell mitotic activity
- Sample lipemic
- Gene re-arrangement, B lymphocyte, light chain
- Cystine below reference range
- Thyroid hormone level below reference range
- Autosomal recessive combined immunodeficiency due to BCL10 mutation
- Abnormal structure of cerebroside
- Autosomal recessive combined immunodeficiency due to MAN2B2 deficiency
- Inv22 - intron 22 inversion
- Missense mutation
- Gene re-arrangement, gamma chain, T cell antigen receptor
- Allelic exclusion
- Multiple marker screen positive for trisomy 18
- Autosomal recessive combined immunodeficiency due to REL proto-oncogene NF-kappa-B subunit mutation
- Increased homogentisic acid
- Autosomal recessive common variable immunodeficiency due to CD20 mutation
- Specific gravity - finding
- Sample grossly icteric
- CYP2C9 *6/*6 poor metabolizer
- Structural variant
- Influenza A H1N1 virus 2009 pandemic strain present
- GU test finding
- Autosomal dominant combined variable immunodeficiency due to IRF2BP2 mutation
- Increased histidine
- Ketone bodies above reference range
- Constitutional mismatch repair deficiency syndrome
- Decreased protein-bound iodine
- Urobilinogen level below reference range
- NAT2 (N-acetyltransferase 2) slow acetylator
- Folic acid above reference range
- Autosomal recessive combined immunodeficiency due to REL mutation
- Satisfactory for evaluation but limited by partially obscuring thick areas
- Autosomal recessive common variable immunodeficiency due to CD21 mutation
- Heterozygous protocadherin 19 gene mutation positive
- VKORC1 poor metaboliser
- Vesicular reaction
- Phosphate calculus of kidney
- Cytochrome P450 family 2 subfamily C member 19 rapid metaboliser
- Heterozygous nuclear factor of kappa light polypeptide gene enhancer In B-cells inhibitor, alpha gene mutation positive
- High risk HPV (human papillomavirus) DNA (deoxyribonucleic acid) detected
- Phosphatase and tensin homolog gene mutation detected
- UTR (untranslated region) mutation
- Autosomal recessive combined immunodeficiency due to component of inhibitor of nuclear factor kappa B kinase complex mutation
- CYP1A2 ultra-rapid metabolizer
- Cytochrome P450 family 2 subfamily C member 9 ultra-rapid metabolizer
- N-acetyltransferase 2 slow acetylator
- Specimen involvement by multifocal invasion
- Karyotype evaluation abnormal
- VKORC1 ultra-rapid metaboliser
- Autosomal recessive combined immunodeficiency due to ITPKB mutation
- Decreased fibrinogen
- Depolymerization
- Finding of presence of crystals
- Increased methaemalbumin
- Increased vanillylmandelic acid level
- Increased vitamin A
- Macromolecular nicking
- Mutation of promoter
- Sample grossly hemolyzed
- Macromolecular binding
- Autosomal recessive combined variable immunodeficiency due to PIK3CG deficiency
- Decreased uroporphyrin
- Finding of amniotic fluid volume
- Autosomal dominant combined variable immunodeficiency due to interferon regulatory factor 2 binding protein 2 mutation
- Synovial fluid: pyrophosphate
- CYP3A5 (cytochrome P450 family 3 subfamily A member 5) ultra-rapid metabolizer
- Protein electrophoresis outside reference range
- CYP3A4 (cytochrome P450 family 3 subfamily A member 4) ultra-rapid metaboliser
- Decreased cystine
- Sample grossly lipemic
- Abnormal macromolecular sequence
- CMMR-D (constitutional mismatch repair deficiency) syndrome
- Orotic acid above reference range
- Autosomal recessive CVID (common variable immunodeficiency) due to CD20 deficiency
- Vitamin K epoxide reductase complex 1 poor metaboliser
- Shrinkage
- Effect of antioestrogen agent
- Amniotic fluid AFP (alpha-fetoprotein) abnormal
- Mutation of untranslated region
- VKORC1 (vitamin K epoxide reductase complex 1) poor metabolizer
- Specimen lipaemic
- Fructose below reference range
- Mannoheptulose below reference range
- Mitochondrial 1555 A to G mutation positive
- Lactose above reference range
- Cytochrome P450 family 2 subfamily C member 9 *2/*3 poor metabolizer
- Folic acid below reference range
- Heterozygous NFKBIA gene mutation positive
- Nonsense mutation
- Alpha-fetoprotein above reference range
- Carbohydrate below reference range
- Oxygen saturation above reference range
- Autosomal dominant combined immunodeficiency due to STAT5b mutation
- Molecular conformation
- Multiple marker screening test positive for Down syndrome
- CYP3A4 rapid metabolizer
- Synovial fluid bloodstained
- Autosomal recessive combined immunodeficiency due to BCL10 deficiency
- Calculus = triple phosphate
- Cytochrome P450 family 2 subfamily C member 9 *6/*11 poor metabolizer
- CYP2D6 rapid metabolizer
- Progressive microcephaly, seizures, cortical blindness, developmental delay syndrome
- Orotic acid below reference range
- Fructose above reference range
- Joint fluid hemorrhagic
- Positive genetic finding
- CYP2C9 (cytochrome P450 family 2 subfamily C member 9) rapid metabolizer
- Abnormal presence of myoglobin
- Tyrosine above reference range
- Finding of bone marrow erythropoiesis
- Positive for tumor protein p53
- CYP3A5 ultra-rapid metabolizer
- Autosomal recessive combined variable immunodeficiency due to phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma mutation
- CYP1A2 rapid metabolizer
- Autosomal recessive common variable immunodeficiency due to BOB1 deficiency
- CYP2C9 *6/*6 poor metaboliser
- VKORC1 rapid metabolizer
- Cytochrome P450 family 2 subfamily C member 9 poor metabolizer
- Increased mannoheptulose
- Molecular instability
- Conformational change
- Decreased beta amino isobutyric acid
- ATP binding cassette subfamily G member 2 decreased function
- Autosomal dominant CVID (combined variable immunodeficiency) due to TNFSF12 mutation
- NAT 2 (N-acetyltransferase 2) poor metaboliser
- Phosphate kidney stone
- Methemalbumin below reference range
- Specimen slightly lipemic
- Vitamin K epoxide reductase complex 1 rapid metabolizer
- CYP1A2 rapid metaboliser
- Denaturation
- High risk HPV (human papillomavirus) test positive
- Sample lipaemic
- Influenza A virus subtype H1 present
- Addition-deletion mutation
- CYP2C9 poor metaboliser
- Cytochrome P450 family 2 subfamily C member 19 rapid metabolizer
- Triplicated alpha globin gene
- Ascorbic acid above reference range
- Specimen slightly haemolysed
- CYP2D6 rapid metaboliser
- Intron 1 inversion
- Beta amino isobutyric acid below reference range
- Cytochrome P450 family 2 subfamily C member 9 *2/*3 poor metaboliser
- Autosomal recessive combined immunodeficiency due to c-Rel deficiency
- Decreased adenosine monophosphate
- Foetal tissue present in specimen
- Decreased histidine
- Autosomal recessive combined variable immunodeficiency due to BAFF receptor deficiency
- Galactose above reference range
- Cytokeratin 19 fragment above reference range
- Progressive microcephaly, seizures, cortical blindness, developmental delay with combined immunodeficiency due to DIAPH1 mutation
- Breast cancer genetic marker of susceptibility positive
- Abnormal presence of pentose
- CYP2C9 (cytochrome P450 family 2 subfamily C member 9) ultra-rapid metaboliser
- CYP4F2 (cytochrome P450 family 4 subfamily F member 2) poor metabolizer
- Finding of presence of ova cysts and parasites
- VKORC1 (vitamin K epoxide reductase complex 1) ultra-rapid metaboliser
- Cytochrome P450 family 2 subfamily C member 9 *6/*6 poor metabolizer
- Cytochrome P450 family 2 subfamily D member 6 rapid metabolizer
- Human papillomavirus deoxyribonucleic acid test positive
- Increased ceroid
- Synovial fluid: fibrin clot +
- Joint fluid haemorrhagic
- High cancer antigen 27-29 level
- Autosomal dominant CVID (combined variable immunodeficiency) due to NFKB1 deficiency
- Abnormal presence of haemoglobin
- Measurement finding below reference range
- Autosomal recessive combined immunodeficiency due to IKK-alpha deficiency
- Rarefaction
- Abnormally soft consistency
- Presence of crystals - finding
- Down syndrome detected by multiple marker screening
- Adenylic acid above reference range
- Unstable molecule
- Tumour protein p53 detected
- Increase in circumference
- VKORC1 (vitamin K epoxide reductase complex 1) ultra-rapid metabolizer
- Abnormal thickness
- Lactose below reference range
- Decreased globulin
- Autosomal dominant combined variable immunodeficiency due to SEC61 translocon subunit alpha 1 mutation
- Decreased cell mitotic activity
- Decreased pentose
- Autosomal dominant combined variable immunodeficiency due to TWEAK deficiency
- CYP2C19 rapid metaboliser
- CYP3A4 ultra-rapid metaboliser
- Cytochrome P450 family 1 subfamily A member 2 rapid metaboliser
- Stringing of synovial fluid
- Finding of monocyte count
- Macromolecular alteration
- Cytochrome P450 family 3 subfamily A member 5 ultra-rapid metabolizer
- Bone marrow normoblastic
- Autosomal recessive combined variable immunodeficiency due to B cell-activating factor receptor mutation
- Increased orotic acid
- Vitamin E above reference range
- Combined immunodeficiency due to IKZF2 mutation
- Autosomal recessive common variable immunodeficiency due to CD21 deficiency
- Increased carbohydrate
- Increased adenosine monophosphate
- Fetal tissue present in specimen
- Joint fluid bloody
- VKORC1 rapid metaboliser
- Synovial fluid composition - finding
- Vitamin K epoxide reductase complex 1 poor metabolizer
- Autosomal recessive common variable immunodeficiency due to MS4A1 mutation
- Blood in synovial fluid
- K19 (keratin-19) fragment above reference range
- Cholesterol/high density lipoprotein ratio above reference range
- Lactic acid level above reference range
- Increased beta amino isobutyric acid
- Sample slightly lipemic
- Autosomal recessive combined variable immunodeficiency due to BAFF-R deficiency
- Autosomal recessive common variable immunodeficiency due to POU class 2 homeobox associating factor 1 mutation
- Specimen icteric
- Vitamin A above reference range
- Abnormal molecular cross-linking
- Tissue specimen fragmented
- Cytochrome P450 family 2 subfamily D member 6 rapid metaboliser
- Measurement finding above reference range
- Genetic susceptibility to malignant hyperthermia due to calcium voltage-gated channel subunit alpha1 S gene mutation positive
- Decreased xanthine
- Synonymous single nucleotide substitution
- Finding of oligohydramnios
- Progressive microcephaly, seizures, cortical blindness, developmental delay syndrome with combined immunodeficiency due to diaphanous related formin 1 mutation
- Decreased urobilinogen level
- High-risk HPV (human papillomavirus) DNA test positive
- Cytochrome P450 family 3 subfamily A member 4 rapid metaboliser
- Decreased choline
- Synovial fluid yellow
- Decreased ascorbic acid
- Abnormal amino acid sequence
- Cytochrome P450 family 3 subfamily A member 4 poor metaboliser
- Foetal anomaly present in specimen
- Increased vitamin D
- Extra chromosomal inheritance
- CYP2C9 *5/*6 poor metabolizer
- Finding related to physiologic substance
- Choline below reference range
- Autosomal dominant CVID (combined variable immunodeficiency) due to SEC61A1 deficiency
- Decreased thyroid hormone level
- Depolymerisation
- Specimen slightly lipaemic
- Positive for tumour protein p53
- Bone marrow iron finding
- ATP binding cassette subfamily G member 2 poor function
- Abnormal structure of phospholipid
- Decreased methaemalbumin
- Genetic susceptibility to malignant hyperthermia due to calcium voltage-gated channel subunit alpha1 S gene mutation
- CYP3A4 (cytochrome P450 family 3 subfamily A member 4) ultra-rapid metabolizer
- Superhelicity
- Cytochrome P450 family 2 subfamily C member 9 *5/*6 poor metabolizer
- Mutation of p53 gene
- Abnormally increased laxness
- Laxity
- CYP3A4 poor metaboliser
- Cytochrome P450 family 3 subfamily A member 4 ultra-rapid metaboliser
- Decreased mannoheptulose
- CYP3A4 (cytochrome P450 family 3 subfamily A member 4) rapid metabolizer
- Somatic mutation
- Genetic susceptibility to malignant hyperthermia
- Mutation of p53 gene present
- Genetic variation
- Autosomal recessive combined immunodeficiency due to CHUK mutation
- BRAF serine threonine kinase gene mutation detected
- Temperature-sensitive mutation
- Increased folic acid
- VKORC1 poor metabolizer
- Autosomal recessive combined immunodeficiency due to ITPKB deficiency
- Decreased folic acid
- Sample grossly lipaemic
- CYP2D6 (cytochrome P450 family 2 subfamily D member 6) rapid metabolizer
- Calculus = cholesterol
- VKORC1 (vitamin K epoxide reductase complex 1) rapid metaboliser
- Specimen too thick for optimal interpretation
- Specimen grossly hemolyzed
- Genitourinary test finding
- Point mutation
- Absent bone marrow iron
- Glucose level above reference range
- HPV (human papillomavirus) DNA (deoxyribonucleic acid) test positive
- Cytochrome P450 family 1 subfamily A member 2 ultra-rapid metabolizer
- Cytochrome P450 family 2 subfamily C member 9 *6/*11 poor metaboliser
- Decreased fructose
- Increased laxness
- Autosomal dominant combined variable immunodeficiency due to IRF2BP2 deficiency
- Decreased macromolecular binding
- Genetic linkage equilibrium
- Gene re-arrangement, alpha chain, T cell antigen receptor
- CYP1A2 (cytochrome P450 family 1 subfamily A member 2) rapid metaboliser
- Abnormal consistency
- Decreased uric acid level
- Increased urobilinogen level
- Vitamin K epoxide reductase complex 1 rapid metaboliser
- Alpha-fetoprotein raised
- Gene re-arrangement, beta chain, T cell antigen receptor
- Triple screening test positive for Down syndrome
- Effect of antiestrogen agent
- Amount of liquor
- Monocyte count abnormal
- Finding of synovial fluid appearance
- Mitochondrial mutation
- Diminution of size
- Sample slightly haemolysed
- Retraction
- Aceto-white reaction finding
- Meiotic alteration
- High risk variant of APOL1 (apolipoprotein L1) gene detected
- Finding of calculus chemical composition
- Increased vitamin B12
- Sample grossly haemolysed
- Urobilinogen level above reference range
- Finding of bilirubin level
- High risk human papillomavirus deoxyribonucleic acid detected
- Autosomal recessive common variable immunodeficiency due to CR2 mutation
- CYP2C19 rapid metabolizer
- Keratin, type I cytoskeletal 19 fragment above reference range
- Autosomal recessive CVID (combined variable immunodeficiency) due to PIK3CG deficiency
- Cytochrome P450 family 2 subfamily C member 9 ultra-rapid metaboliser
- Genetic inversion
- Autosomal dominant combined variable immunodeficiency due to tumour necrosis factor-like weak inducer of apoptosis mutation
- Autosomal dominant combined variable immunodeficiency due to NFKB1 mutation
- Autosomal dominant combined variable immunodeficiency due to tumor necrosis factor-like weak inducer of apoptosis mutation
- Abnormal translucency
- Defective molecular assembly
- Human epidermal growth factor receptor 2 gene amplification detected
- Low risk variant of apolipoprotein L1 gene detected
- Decreased vitamin B
- Abnormally decreased organ weight
- CYP1A2 (cytochrome P450 family 1 subfamily A member 2) rapid metabolizer
- Elevated cholesterol/high density lipoprotein ratio
- CYP3A4 poor metabolizer
- Strand breaks
- Decreased adenylic acid
- Increased tyrosine
- Increased lactose
- Sample slightly hemolyzed
- Satisfactory for evaluation but limited by partially obscuring air drying artefact
- Increased biliverdin
- Increased vitamin E
- Finding of quantity of liquor
- Increased vitamin C
- Positive skin test reaction
- PTEN (phosphatase and tensin homolog) gene mutation detected
- Splice site mutation
- Monocyte count
- Finding of organ weight
- Bilirubin level - finding
- CYP1A2 (cytochrome P450 family 1 subfamily A member 2) ultra-rapid metaboliser
- Vitamin K above reference range
- Cytochrome P450 family 2 subfamily C member 9 rapid metabolizer
- Aceto-white reaction positive
- Synovial fluid fibrin clot
- Gene re-arrangement, B lymphocyte, heavy chain
- Liquor volume below reference range
- CYP4F2 poor metabolizer
- Autosomal recessive CVID (combined variable immunodeficiency) due to ARHGEF1 deficiency
- Increased diameter
- Amniotic fluid volume below reference range
- Quantity of physiologic substance outside reference range
- Vanillylmandelic acid level above reference range
- CYP2C9 *2/*3 poor metabolizer
- Xanthine above reference range
- High risk human papillomavirus positive
- AFP - Alpha-fetoprotein raised
- Autosomal recessive combined variable immunodeficiency due to ARHGEF1 mutation
- Joint fluid cloudy
- Nucleotide base deletion
- Sample haemolysed
- Bilirubin level below reference range
- Bilirubin level
- Smear too thick for optimal interpretation
- Cold agglutinins detected
- Fetal anomaly present in specimen
- Sample icteric
- CYP2C9 *6/*8 poor metaboliser
- Increased choline
- Granulocyte count below reference range
- Increased nuchal translucency detected by multiple marker screening
- Presence of ova cysts and parasites - finding
- Reading-frame-shift mutation
- Autosomal recessive combined immunodeficiency due to BCL10 immune signaling adaptor mutation
- Autosomal recessive combined immunodeficiency due to inositol-trisphosphate 3-kinase B mutation
- CYP2C9 (cytochrome P450 family 2 subfamily C member 9) rapid metaboliser
- Specimen grossly haemolysed
- Tissue specimen ruptured
- Cytochrome P450 family 2 subfamily C member 9 *6/*6 poor metaboliser
- Fragmented tissue specimen
- CYP3A4 (cytochrome P450 family 3 subfamily A member 4) rapid metaboliser
Frequently Asked Questions
What is the ICD-10 code for oth abnormal findings in specimens from oth org/tiss?
The ICD-10-CM code for oth abnormal findings in specimens from oth org/tiss is R89.8. The full clinical description is "Other abnormal findings in specimens from other organs, systems and tissues". R89.8 is a billable/specific code that can be used on insurance claims and medical billing.
What does ICD-10 code R89.8 mean?
ICD-10-CM code R89.8 represents “Other abnormal findings in specimens from other organs, systems and tissues”. It is classified under Chapter 18: Symptoms, Signs and Abnormal Clinical and Laboratory Findings and is a billable/specific code that can be used on a claim.
Is R89.8 a billable code?
Yes, R89.8 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is R89.8 in?
R89.8 is in Chapter 18: Symptoms, Signs and Abnormal Clinical and Laboratory Findings (codes R00-R99).
What codes cannot be used with R89.8?
R89.8 has Excludes1 notes indicating codes that cannot be used together with it, including: abnormal findings on antenatal screening of mother (O28.-); diagnostic abnormal findings classified elsewhere - see Alphabetical Index.
What SNOMED CT codes does R89.8 map to?
R89.8 maps to 331 SNOMED CT concepts: 1351233008, 1351232003, 166561008, 69604007, 42170009, and 326 more. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for R89.8?
R89.8 is linked to 2 UMLS Concept Unique Identifiers: C2830575, C0478185. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
How does R89.8 relate to ICF functioning codes?
ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like oth abnormal findings in specimens from oth org/tiss affect a person's functioning — body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.
What is the ICD-11 equivalent of R89.8?
R89.8 maps to the ICD-11 code: MG6Y (Other specified clinical findings in specimens from other specified organs, systems and tissues).
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.